Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Summary of the Evidence for the U.S. Preventive Services Task Force

Established in 1927 by the American College of Physicians

Abstract/Editors' Note | Full Text

FIGURES/TABLES SUMMARY PAGE

PowerPoint slides are available for most Figures at Annals.org

Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Summary of the Evidence for the U.S. Preventive Services Task Force

View larger version (26K):
[in this window]
[in a new window]

Figure 1. Analytic framework for screening for chronic obstructive pulmonary disease (COPD) using spirometry.

M/M = morbidity and mortality.

View this table:
[in this window]
[in a new window]

Appendix Table 1. U.S. Preventive Services Task Force Hierarchy of Research Design and Quality Rating Criteria*

View this table:
[in this window]
[in a new window]

Appendix Table 2. Systematic Literature Reviews on Adverse Effects of Pharmacologic Therapies for Chronic Obstructive Pulmonary Disease*

View this table:
[in this window]
[in a new window]

Appendix Table 3. Adverse Effects of Pharmacologic Treatments for Chronic Obstructive Pulmonary Disease*

View this table:
[in this window]
[in a new window]

Table 1. Projected Outcomes of Screening 10 000 Asymptomatic Adults for Chronic Obstructive Pulmonary Disease Using Spirometry*

View larger version (53K):
[in this window]
[in a new window]

Figure 2. Projected outcomes of population-based screening for chronic obstructive pulmonary disease (COPD) using spirometry in current smokers age 40 years or older.

NHANES = National Health and Nutrition Examination Survey.

View this table:
[in this window]
[in a new window]

Table 2. Summary of Evidence*

View larger version (42K):
[in this window]
[in a new window]

Appendix Figure 1. Study flow diagram: key question 3.

COPD = chronic obstructive pulmonary disease.

View larger version (52K):
[in this window]
[in a new window]

Appendix Figure 2. Study flow diagram: key question 4.

View larger version (49K):
[in this window]
[in a new window]

Appendix Figure 3. Study flow diagram: key question 6.